Case Based Peer Perspectives


Targeted Oncology presents Case-Based Peer Perspectives. In each video, expert physicians provide insight on managing oncology-based patient cases that highlight the use of novel agents in clinical practice.

A 70-Year-Old Man with Anemia in ESA Naive Lower-Risk Myelodysplastic Syndrome (LR-MDS)

A 70-Year-Old Man with Anemia in ESA Naive Lower-Risk Myelodysplastic Syndrome (LR-MDS)

June 12th 2025

Read More

First-Line Treatment for EGFR-mutated Advanced/Metastatic Non-Small-Cell Lung Cancer: A 55-Year-Old Man

First-Line Treatment for EGFR-mutated Advanced/Metastatic Non-Small-Cell Lung Cancer: A 55-Year-Old Man

June 5th 2025

Read More

A 74-Year-Old Woman with Newly Diagnosed Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

A 74-Year-Old Woman with Newly Diagnosed Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

April 24th 2025

Read More

Treatment Advances in Graft-Vs-Host Disease: A 48-Year-Old Man With Chronic Graft-Vs-Host Disease

Treatment Advances in Graft-Vs-Host Disease: A 48-Year-Old Man With Chronic Graft-Vs-Host Disease

March 31st 2025

Read More

1 KOL is featured in this series.

A 53-Year-Old Woman With Metastatic Nasopharyngeal Carcinoma

March 10th 2025

Read More

A 48-Year-Old Man With Recurrent Nasopharyngeal Carcinoma and a 53-Year-Old Woman With Metastatic Nasopharyngeal Carcinoma

A 48-Year-Old Man With Recurrent Nasopharyngeal Carcinoma and a 53-Year-Old Woman With Metastatic Nasopharyngeal Carcinoma

March 10th 2025

Read More

A 48-Year-Old Man with Recurrent Nasopharyngeal Carcinoma

A 48-Year-Old Man with Recurrent Nasopharyngeal Carcinoma

March 5th 2025

Read More

Emerging Treatment Landscape in MPNs: From Current Practice to Emerging Therapies

Emerging Treatment Landscape in MPNs: From Current Practice to Emerging Therapies

March 4th 2025

Read More

1 expert in this video

A 62-Year-Old Man With Newly Diagnosed Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

February 28th 2025

Read More

1 expert in this video

Therapeutic Sequencing for Relapsed/Refractory Metastatic Renal Cell Carcinoma: The Case of a 65-year-old Patient

February 26th 2025

Read More

1 expert in this video

Treatment Insights in Intermediate- and Advanced-Stage Unresectable Hepatocellular Carcinoma: A 57-Year-Old Patient

February 25th 2025

Read More

Advancing the Treatment Landscape in Polycythemia Vera (PV): Patient-Centered Approaches

Advancing the Treatment Landscape in Polycythemia Vera (PV): Patient-Centered Approaches

February 25th 2025

Read More

1 expert in this video

Treatment Insights in Intermediate and Advanced Stage Unresectable Hepatocellular Carcinoma: The Case of a 60-Year-Old Man

February 25th 2025

Read More

Updates in Use of ARIs and Ra-223 for Metastatic Castration-Resistant Prostate Cancer

Updates in Use of ARIs and Ra-223 for Metastatic Castration-Resistant Prostate Cancer

February 20th 2025

Read More

1 expert is featured in this series.

Therapeutic Sequencing for Relapsed/Refractory Metastatic Renal Cell Carcinoma

February 19th 2025

Read More

1 expert in this video

First-Line Treatment for EGFR-mutated Advanced/Metastatic Non-Small-Cell Lung Cancer: A 47-Year-Old Woman

February 6th 2025

Read More

A 66-Year-Old Woman with Later Relapsed/Refractory Multiple Myeloma

A 66-Year-Old Woman with Later Relapsed/Refractory Multiple Myeloma

January 20th 2025

Read More

A 60-Year-Old Man With Early Relapse/Refractory Multiple Myeloma

A 60-Year-Old Man With Early Relapse/Refractory Multiple Myeloma

December 18th 2024

Read More

Practice Updates in Use of ARIs for Metastatic Prostate Cancer

Practice Updates in Use of ARIs for Metastatic Prostate Cancer

December 16th 2024

Read More

1 expert in this video

Case-Based Peer Perspectives: A 72-Year-Old Man With Relapsed/Refractory Multiple Myeloma (RRMM)

December 5th 2024

Read More

Advances in Targeted Therapy for Small Cell Lung Cancer

Advances in Targeted Therapy for Small Cell Lung Cancer

October 7th 2024

Read More

Advances in Targeted Therapy for Small Cell Lung Cancer

Advances in Targeted Therapy for Small Cell Lung Cancer

September 30th 2024

Read More

Solly Chedid, MD, an expert on MDS

Frontline Use of Erythroid Maturating Agent (EMA): Luspatercept

August 27th 2024

Read More

Jamie L. Koprivnikar, MD, an expert on MDS

SF3B1+ MDS-RS: IPSS-M-Guided 1L Luspatercept

August 26th 2024

Read More

1 KOL is featured in this series

LR-MDS with Transfusion-Dependent Anemia – ESA Refractory, RS+

August 7th 2024

Read More

First in Class Telomerase Inhibitor (Imetelstat) for Lower-Risk Myelodysplastic Syndromes (LR-MDS)

First in Class Telomerase Inhibitor (Imetelstat) for Lower-Risk Myelodysplastic Syndromes (LR-MDS)

July 29th 2024

Read More

Caitlin Costello, MD, an expert on multiple myeloma

A 60-Year-Old Woman with Later Relapsed/Refractory Multiple Myeloma

July 24th 2024

Read More

1 KOL is featured in this series

Frontline Use of Erythroid Maturating Agent (EMA): Luspatercept

June 27th 2024

Read More

Sham Mailankody, MBBS, an expert on multiple myeloma

A 70-Year-Old Man with Early Relapse/Refractory Multiple Myeloma

June 20th 2024

Read More

Targeted Onc - 1 KOL is featured in "A 73-Year-Old Man with Metastatic Urothelial Carcinoma"

A 73-Year-Old Man with Metastatic Urothelial Carcinoma

June 11th 2024

Read More

12345678
...
17>